Rika A. Furuta1, Takayuki Miyazawa2, Takeki Sugiyama3, Takafumi Kimura1, Fumiya Hirayama1, Yoshihiko Tani1 and Hirotoshi Shibata1 1 Department of Research, Japanese Red Cross Osaka Blood Center, 2 Laboratory for Viral pathogenesis, Institute for Virus Research, Kyoto University, 3 Department of Urology, Nishiwaki Municipal Hospital.
Suzanne D. Vernon, PhD Scientific Director The CFIDS Association of America
Frank J M van Kuppeveld, associate professor experimental virology,1,5,6 Arjan S de Jong, molecular medical microbiologist,1,5 Kjerstin H Lanke, research technician,1,5,6 Gerald W Verhaegh, senior research fellow,2,6 Willem J G Melchers, molecular medical microbiologist,1,5,6 CarolineMA Swanink, medical microbiologist,1 Gijs Bleijenberg, professor psychology,4,5,7 Mihai G Netea, professor experimental internal medicine,3,5 Jochem M D Galama, professor clinical virology,1,5 Jos W M van der Meer, professor internal medicine3,5
17 februari 2010 Author: Judy Mikovits
Suzanne D. Vernon, PhD Scientific Director The CFIDS Association of America
Retrovirology. 2010, 7:10. doi:10.1186/1742-4690-7-10. Groom HCT, Boucherit VC, Makinson K, Randal E, Baptista S, Hagan S, Gow JW, Mattes FM, Breuer J, Kerr JR, Stoye JP, Bishop KN.
By Fred Friedberg, PhD, President, IACFS/ME
Brenu EW, Staines DR, Baskurt OK, Ashton KJ, Ramos SB, Christy RM, Marshall-Gradisnik SM.
The Whittemore Peterson Institute (WPI) has reviewed the paper entitled "Failure to Detect the Novel Retrovirus XMRV in Chronic Fatigue Syndrome." This study did not duplicate the rigorous scientific techniques used by WPI, the National Cancer Institute and the Cleveland Clinic, therefore it cannot be considered a replication study nor can the results claim to be anything other than a failure not just to detect XMRV, but also a failure to suggest meaningful results.
Two charities are joining forces to fund research into ME/CFS. ME Solutions and Invest in ME are working together to maximise the opportunities to fund research into ME/CFS. The research project is - The role of XMRV in modulation of NK cell cytotoxicity and NK cell gene abnormalities in ME/CFS patients and normal blood donors.
ESME.com is designed, developed and hosted by Norsk Kunde & Medlemsutvikling